Vox Markets Interview with Avacta CEO Alastair Smith

0 Mga view· 09/19/23
The Vox Markets Podcast
The Vox Markets Podcast
0 Mga subscriber
0
Sa

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

Magpakita ng higit pa

 0 Mga komento sort   Pagbukud-bukurin Ayon


Susunod